Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-01-09 @ 10:58 PM
Study NCT ID:
NCT06484920
Status:
RECRUITING
Last Update Posted:
2025-02-03
First Post:
2024-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Sponsor:
Rita Assi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-19
First Submit QC Date:
None
Study First Post Date:
2024-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-30
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL